XML 62 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Income Taxes (Tables)
12 Months Ended
Jun. 30, 2018
Income Tax Disclosure [Abstract]  
Schedule of Income Before Income Tax, Domestic and Foreign
The following table summarizes earnings/(loss) before income taxes:
(in millions)
2018
 
2017
 
2016
U.S. operations
$
391

 
$
1,772

 
$
2,050

Non-U.S. operations
(619
)
 
152

 
226

Earnings/(loss) before income taxes
$
(228
)
 
$
1,924

 
$
2,276

Schedule of Components of Income Tax Expense (Benefit), Current and Deferred
The following table summarizes the components of provision for/(benefit from) income taxes:
(in millions)
2018
 
2017
 
2016
Current:
 
 
 
 
 
Federal
$
341

 
$
273

 
$
633

State and local
41

 
10

 
52

Non-U.S.
143

 
56

 
73

Total current
$
525

 
$
339

 
$
758

 
 
 
 
 
 
Deferred:
 
 
 
 
 
Federal
$
(1,003
)
 
$
258

 
$
96

State and local
16

 
37

 
12

Non-U.S.
(25
)
 
(4
)
 
(21
)
Total deferred
(1,012
)
 
291

 
87

Provision for/(benefit from) income taxes
$
(487
)
 
$
630

 
$
845

Schedule of Effective Income Tax Rate Reconciliation
The following table presents a reconciliation of the provision based on the federal statutory income tax rate to our effective income tax rate:
 
2018 (1)
 
2017 (2)
 
2016 (2)
Provision at Federal statutory rate
28.1
 %
 
35.0
 %
 
35.0
 %
State and local income taxes, net of federal benefit
(16.0
)
 
1.0

 
1.5

Foreign tax rate differential
(48.4
)
 
(7.3
)
 
(0.6
)
Nondeductible/nontaxable items
(10.2
)
 
0.2

 
1.0

Goodwill impairment
(124.7
)
 

 

Tax Act
410.9

 

 

Capital loss
71.4

 

 

Change in valuation allowances
(76.9
)
 
7.7

 
0.1

Foreign tax credits
27.3

 
(1.6
)
 
(0.1
)
China tax related to divestiture
(25.8
)
 

 

Other
(21.9
)
 
(2.3
)
 
0.2

Effective income tax rate
213.8
 %
 
32.7
 %
 
37.1
 %
Schedule of Deferred Tax Assets and Liabilities
The following table presents the components of the deferred income tax assets and liabilities at June 30:
(in millions)
2018
 
2017
Deferred income tax assets:
 
 
 
Receivable basis difference
$
41

 
$
42

Accrued liabilities
110

 
125

Share-based compensation
40

 
53

Loss and tax credit carryforwards
526

 
378

Deferred tax assets related to uncertain tax positions
30

 
51

Other
101

 
43

Total deferred income tax assets
848

 
692

Valuation allowance for deferred income tax assets
(412
)
 
(237
)
Net deferred income tax assets
$
436

 
$
455

 
 
 
 
Deferred income tax liabilities:
 
 
 
Inventory basis differences
$
(1,103
)
 
$
(1,578
)
Property-related
(176
)
 
(183
)
Goodwill and other intangibles
(934
)
 
(570
)
   Total deferred income tax liabilities
$
(2,213
)
 
$
(2,331
)
Net deferred income tax liability
$
(1,777
)
 
$
(1,876
)
Schedule of Deferred Tax Assets and Liabilities after Netting by Tax Jurisdiction
Deferred income tax assets and liabilities in the preceding table, after netting by taxing jurisdiction, are in the following captions in the consolidated balance sheets at June 30:
(in millions)
2018
 
2017
Noncurrent deferred income tax asset (1)
37

 
73

Noncurrent deferred income tax liability (2)
(1,814
)
 
(1,949
)
Net deferred income tax liability
$
(1,777
)
 
$
(1,876
)

(1)
Included in other assets in the consolidated balance sheets.
(2)
Included in deferred income taxes and other liabilities in the consolidated balance sheets.
Schedule of Unrecognized Tax Benefits Roll Forward
sheets. The following table presents a reconciliation of the beginning and ending amounts of unrecognized tax benefits:
(in millions)
2018
 
2017
 
2016
Balance at beginning of fiscal year
$
417

 
$
527

 
$
542

Additions for tax positions of the current year
15

 
29

 
22

Additions for tax positions of prior years (1)
141

 
23

 
42

Reductions for tax positions of prior years
(40
)
 
(8
)
 
(48
)
Settlements with tax authorities (1)
(99
)
 
(154
)
 
(30
)
Expiration of the statute of limitations (1)
(11
)
 

 
(1
)
Balance at end of fiscal year
$
423

 
$
417

 
$
527


(1)
Included in additions for tax positions of prior years is $110 million related to exposures acquired as part of the Patient Recovery Business for which we are indemnified. Settlements of $81 million related to the Patient Recovery Business as well as $11 million of statute expirations.